Written by: Prethy Rao, MD Zhu X, Shen P, Li C, Li H, Huang H, Shi K, Wang L, Zhang X, Lu L. Retina. 2019 Jul;39(7):1305-1311 Myopic macular foveoschisis in patients is often a daunting clinical finding in many practices as progression and surgical outcomes are often variable. While present in 15-20% of myopic patients, […]
Written by: Katherine E. Talcott, MD Lindtjorn B, Krohn J Austeng D et al. Nonsupine positioning after macular hole surgery: a prospective multicenter study. Ophthalmol Retina. 2019 May;3(5):388-92. Macular hole (MH) surgical repair typically involves the release of tangential traction on the retina by lifting the hyaloid, removal of the internal limiting membrane, epiretinal membrane, […]
Written by: Prethy Rao, MD Falavarjani K.G., Hadi Y., Habibi A., Anvari P., Modarres M., Parvaresh M.M.,Jafari S. & Alemzadeh S.A. Ophthalmol Retina. 2019 Jun;3(6):538-539 We live in an exciting time in retina with new pathway drugs being rolled into clinical trials and markets—from TIE2 receptors, DARPins, smaller VEGF antibody fragments (conbercerpt, brolicizumab) etc—for both macular […]
Written by: Maxwell S. Stem, MD Felfeli T, Mandelcorn ED. MACULAR HOLE HYDRODISSECTION: Surgical Technique for the Treatment of Persistent, Chronic, and Large Macular Holes. Retina. 2019;39(4):743-752. While the vast majority of full thickness macular holes (MH) close with standard vitrectomy surgery, peeling of the internal limiting membrane (ILM), and gas tamponade, there exists a […]
Written by: Maxwell S. Stem, MD Hillier RJ, Felfeli T, Berger AR, et al. The Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT). Ophthalmology. 2019;126(4):531-539. The optimal management of a primary, uncomplicated rhegmatogenous retinal detachment (RRD) is a matter of some debate among vitreoretinal surgeons. Recently, Hillier […]
Written by: Judy J. Chen, MD Dalvin LA, Starr MR, AbouChehade JE, et al. Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy with Risk of Stroke, Myocardial Infarction, and Death in Patients with Exudative Age-Related Macular Degeneration. JAMA Ophthalmol. 2019;137(5):483-490. Ever since intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents became the mainstay of […]
Written by: Judy Chen, MD Baker CW, Glassman AR, Beaulieu WT, et al. Effect of Initial Management of Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial. JAMA 2019 Apr 29 [Epub ahead of print]. […]
